Search Results - "van Muijen, M. E."

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide by van Muijen, M. E., van der Schoot, L. S., van den Reek, J. M. P. A., de Jong, E. M. G. J.

“…Dose reduction (DR) of biologics, where possible, seems promising for more efficient use of expensive biologics. For implementation of DR strategies, it is…”
Get full text

Corrigendum: Dose reduction of biologics in patients with plaque psoriasis: a review by van Riel, C A M, Michielsens, C A J, van Muijen, M E, van der Schoot, L S, van den Reek, J M P A, de Jong, E M G J

“…[This corrects the article DOI: 10.3389/fphar.2024.1369805.]…”
Get full text

Dose reduction of biologics in patients with plaque psoriasis: a review by van Riel, C A M, Michielsens, C A J, van Muijen, M E, van der Schoot, L S, van den Reek, J M P A, de Jong, E M G J

“…Dose reduction (DR) of first-generation biologics for plaque psoriasis (TNF-alpha inhibitors (i) and interleukin (IL)-12/23i) has been described in a previous…”
Get full text

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review by Michielsens, C. A. J., van Muijen, M. E., Verhoef, L. M., van den Reek, J. M. P. A., de Jong, E. M. G. J

“…Introduction Biologics serve as a cornerstone in psoriasis treatment, with low disease activity or sometimes even clinical remission as a realistic treatment…”
Get full text

The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy by van Muijen, Marloes E, van Hal, Tamara W, Groenewoud, Hans M M, van den Reek, Juul M P A, de Jong, Elke M G J

“…Previously identified risk factors for psoriatic arthritis (PsA); nail dystrophy and scalp lesions are highly prevalent in patients with moderate-to-severe…”
Get full text